TD Vaccine System

BIOLOGICAL2 trials

Sponsors

Intercell USA, Inc.

Conditions

Traveler's DiarrheaTravelers' Diarrhea

Phase 2

Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study

CompletedNCT01040325

Intercell USA, Inc.Traveler's Diarrhea

Start: 2009-12-31End: 2010-12-31Updated: 2012-03-14

Phase 3

Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study

CompletedNCT00993681

Intercell USA, Inc.Travelers' Diarrhea

Start: 2009-10-31End: 2011-04-30Updated: 2012-03-14

Related Papers

Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.

2013-11-2964 citations